TASSI, Renata Alessandra
 Distribuzione geografica
Continente #
NA - Nord America 1.564
EU - Europa 626
AS - Asia 246
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.440
Nazione #
US - Stati Uniti d'America 1.550
PL - Polonia 249
CN - Cina 183
UA - Ucraina 127
DE - Germania 90
IT - Italia 49
FI - Finlandia 47
HK - Hong Kong 36
GB - Regno Unito 24
IE - Irlanda 19
CA - Canada 13
FR - Francia 11
SG - Singapore 10
SE - Svezia 8
VN - Vietnam 8
IN - India 4
EU - Europa 3
LK - Sri Lanka 2
NL - Olanda 2
AZ - Azerbaigian 1
BR - Brasile 1
CR - Costa Rica 1
KZ - Kazakistan 1
TR - Turchia 1
Totale 2.440
Città #
Warsaw 248
Fairfield 230
Woodbridge 197
Ashburn 123
Houston 119
Seattle 115
Ann Arbor 97
Jacksonville 93
Dearborn 84
Wilmington 82
Cambridge 79
Chandler 68
New York 42
Princeton 38
Hong Kong 36
Helsinki 32
Nanjing 32
Beijing 22
Dublin 19
Jinan 16
Shanghai 15
Shenyang 14
Toronto 13
Nanchang 12
Kunming 10
San Diego 10
Changsha 8
Dong Ket 8
Hebei 8
Monmouth Junction 8
Jiaxing 7
Milan 7
Brescia 6
Des Moines 6
London 6
Tianjin 6
Hangzhou 5
Los Angeles 5
Hefei 4
Leawood 4
Zhengzhou 4
Lancaster 3
Lanzhou 3
Ningbo 3
Taiyuan 3
Colombo 2
Norwalk 2
Phoenix 2
San Francisco 2
Almaty 1
Amsterdam 1
Baku 1
Baotou 1
Chengdu 1
Falkenstein 1
Groningen 1
Guangzhou 1
Gunzenhausen 1
Haikou 1
Hounslow 1
Kilburn 1
Kocaeli 1
Mumbai 1
New Bedfont 1
Newark 1
Orange 1
Padova 1
Redmond 1
Redwood City 1
San José 1
Segrate 1
Southwark 1
Stockholm 1
São Paulo 1
Taizhou 1
Verona 1
Washington 1
Wuhan 1
Xian 1
Zhangzhou 1
Totale 1.989
Nome #
Identification of stably expressed reference small non-coding RNAs for microRNA quantification in high-grade serous ovarian carcinoma tissues 282
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 218
Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy. 147
Correlation between serological immune response analyzed by a new ELISA for HPV-16/18 E7 oncoprotein and clinical characteristics of cervical cancer patients. 141
Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis. 135
Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes 132
Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissues. 125
Trop-2 overexpression as an independent marker for poor overall survival in ovarian carcinoma patients. 124
Overexpression of mammaglobin B in epithelial ovarian carcinomas. 121
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. 119
Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence 118
Trefoil factor 3: a novel serum marker identified by gene expression profiling in highgrade endometrial carcinomas 116
Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma 113
Mammaglobin B expression in human endometrial cancer 112
MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis 110
The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines 106
HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. 104
Claudin-7 expression in human epithelial ovarian cancer 84
Human epididymis protein 4 as a serum marker for diagnosis of endometrial carcinoma and prediction of clinical outcome 83
Totale 2.490
Categoria #
all - tutte 8.518
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.518


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019179 0 0 0 0 0 0 0 0 0 0 81 98
2019/2020783 88 35 31 84 53 124 109 85 57 70 10 37
2020/2021351 9 40 5 59 9 37 26 36 41 38 38 13
2021/2022211 33 38 4 2 0 10 14 13 4 37 20 36
2022/2023203 40 10 13 5 15 39 0 19 36 1 11 14
2023/2024218 14 8 28 26 13 55 14 9 37 10 4 0
Totale 2.490